Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
The fever, which doctors describe as more severe than is usual in this season, mostly affecting children & adults with comorbidities. No life-threatening case so far, doctors say.
No. of H3N2 cases has doubled since last spike in 2021. Experts say low popularity of flu vaccines, comorbidities & allergens in air can be why people are becoming more susceptible to it.
New Delhi: India is looking to induct hypersonic missiles, nuclear propulsion for aircraft carriers and warships, next-gen tanks, a variety of unmanned systems and...
In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?
COMMENTS